O. S. Trofimenko
O. S. Trofimenko has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Elena N. Yushchuk
Russian University of Medicine
3 shared publications - Elizaveta G. Medvedeva
Russian University of Medicine
2 shared publications - I. A. Sadulaeva
Russian University of Medicine
2 shared publications - L. F. Khalikova
Russian University of Medicine
2 shared publications - Dar'JA A. Filonenko
Loginov Moscow Clinical Scientific Center
1 shared publication - Liudmila G. Zhukova
Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia
1 shared publication
Latest Publications
- 21 November 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (10)
Impact of gene polymorphisms on vascular changes in hypertensive patients
Aim. To study the relationship between specific gene polymorphisms and arterial stiffness to assess the impact of these gene polymorphisms on the risk of cardiovascular diseases. Material and methods. Seventy-seven patients, with an average age of 52,9±11,3 years, were examined. Patients underwent clinical and paraclinical examinations, including volume sphygmoplethysmography to assess the cardio-ankle vascular index (CAVI), biochemical blood tests, and gene polymorphism determination. Patients were divided into two groups based on hypertension (HTN) presence. Each group was then divided into three subgroups based on CAVI level as follows: CAVI 9. Results. In the HTN group, the frequency of T/C and T/T genotypes of the AGT C521T polymorphism was higher in all three subgroups compared to the control one. The T/C genotype of the GNB3 C825T polymorphism was more common in the HTN group in the subgroups with CAVI 9, while the T/T genotype was more common in the control group with CAVI of 8,0-8,9. In the subgroup with CAVI of 8,0-8,9, the C/C allele of the NOS3 T786C polymorphism was significantly more common in the control group, while the T/C allele was predominant in the control group with CAVI NOS3 G894T polymorphism was more common, while the T/G allele was more common in the hypertensive group with a CAVI of 8,0-8,9. Conclusion. The AGT C521T polymorphism can serve as a marker of early vascular damage in patients with confirmed HTN. The homozygous C/C genotype of the AGT T704C polymorphism more likely leads to HTN. The study of genetic polymorphisms pushes the boundaries for rethinking the onset and development of HTN and cardiovascular diseases.
- 21 November 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (10)
Impact of gene polymorphisms on vascular changes in hypertensive patients
Aim. To study the relationship between specific gene polymorphisms and arterial stiffness to assess the impact of these gene polymorphisms on the risk of cardiovascular diseases. Material and methods. Seventy-seven patients, with an average age of 52,9±11,3 years, were examined. Patients underwent clinical and paraclinical examinations, including volume sphygmoplethysmography to assess the cardio-ankle vascular index (CAVI), biochemical blood tests, and gene polymorphism determination. Patients were divided into two groups based on hypertension (HTN) presence. Each group was then divided into three subgroups based on CAVI level as follows: CAVI 9. Results. In the HTN group, the frequency of T/C and T/T genotypes of the AGT C521T polymorphism was higher in all three subgroups compared to the control one. The T/C genotype of the GNB3 C825T polymorphism was more common in the HTN group in the subgroups with CAVI 9, while the T/T genotype was more common in the control group with CAVI of 8,0-8,9. In the subgroup with CAVI of 8,0-8,9, the C/C allele of the NOS3 T786C polymorphism was significantly more common in the control group, while the T/C allele was predominant in the control group with CAVI NOS3 G894T polymorphism was more common, while the T/G allele was more common in the hypertensive group with a CAVI of 8,0-8,9. Conclusion. The AGT C521T polymorphism can serve as a marker of early vascular damage in patients with confirmed HTN. The homozygous C/C genotype of the AGT T704C polymorphism more likely leads to HTN. The study of genetic polymorphisms pushes the boundaries for rethinking the onset and development of HTN and cardiovascular diseases.
- Open Access
- 16 May 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (4) , 4272
Analysis of arterial stiffness parameters in breast cancer patients undergoing combination anthracycline-containing chemotherapy
Aim. To identify and analyze changes of arterial stiffness (AS) parameters in breast cancer patients undergoing combination anthracycline-containing chemotherapy (ACCT).Material and methods. Fifty women with verified breast cancer aged 46,7±7 years with indications for combined ACCT were assessed for AS (carotid-femoral pulse wave velocity (cfPWV) (m/s); cardio-ankle vascular index (CAVI); cardio-ankle pulse wave velocity (caPWV) (m/s); β-stiffness index, novel Russian Stelari and haStart indices) at 4 visits as follows: before ACCT, after 8-12, 20-24 and 48 weeks from the ACCT start.Results. A reliable decrease in cfPWV was revealed at visit 2 (7,48±1,51, pConclusion. In patients with breast cancer who underwent combined ACCT, an increase in cfPWV by 0,95 m/s per year was revealed, which indicates accelerated vascular wall aging and a possible increase in cardiovascular risk in this category of patients.
- 16 May 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (4) , 4272
Open AccessAnalysis of arterial stiffness parameters in breast cancer patients undergoing combination anthracycline-containing chemotherapy
Aim. To identify and analyze changes of arterial stiffness (AS) parameters in breast cancer patients undergoing combination anthracycline-containing chemotherapy (ACCT).Material and methods. Fifty women with verified breast cancer aged 46,7±7 years with indications for combined ACCT were assessed for AS (carotid-femoral pulse wave velocity (cfPWV) (m/s); cardio-ankle vascular index (CAVI); cardio-ankle pulse wave velocity (caPWV) (m/s); β-stiffness index, novel Russian Stelari and haStart indices) at 4 visits as follows: before ACCT, after 8-12, 20-24 and 48 weeks from the ACCT start.Results. A reliable decrease in cfPWV was revealed at visit 2 (7,48±1,51, pConclusion. In patients with breast cancer who underwent combined ACCT, an increase in cfPWV by 0,95 m/s per year was revealed, which indicates accelerated vascular wall aging and a possible increase in cardiovascular risk in this category of patients.
- Open Access
- 16 January 2023
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 94 (12) , 1367-1373
Subclinical markers of liver damage in patients with arterial hypertension and obesity
Aim. To investigate the possibility of preclinical detection of liver damage in patients with hypertension and obesity. Materials and methods. The study included 168 patients with hypertension aged 30 to 60 years. All patients underwent general clinical and laboratory-instrumental examination, including ultrasound of the abdominal organs with Doppler assessment of blood flow and determination of markers such as ALT, AST, TG, lipid profile indicators at inclusion, after a month, three months and nine months. Results. Depending on the presence of obesity, all patients with hypertension were divided into two groups. Obese patients had a statistically significant increase in office blood pressure, FSI, the ratio of TG and LDL-C to HDL-C, a more significant higher average levels of glucose, TG and ALT levels, as well as impaired hepatic blood flow according to ultrasound. Conclusion. Indicators of FSI, ALT/AST ratio, ratio of TG and LDL-С to HDL-C as well as assessment of hepatic blood flow indicators can be used for early diagnosis of nonalcoholic fatty liver disease, as they predict liver steatosis.
- 16 January 2023
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 94 (12) , 1367-1373
Open AccessSubclinical markers of liver damage in patients with arterial hypertension and obesity
Aim. To investigate the possibility of preclinical detection of liver damage in patients with hypertension and obesity. Materials and methods. The study included 168 patients with hypertension aged 30 to 60 years. All patients underwent general clinical and laboratory-instrumental examination, including ultrasound of the abdominal organs with Doppler assessment of blood flow and determination of markers such as ALT, AST, TG, lipid profile indicators at inclusion, after a month, three months and nine months. Results. Depending on the presence of obesity, all patients with hypertension were divided into two groups. Obese patients had a statistically significant increase in office blood pressure, FSI, the ratio of TG and LDL-C to HDL-C, a more significant higher average levels of glucose, TG and ALT levels, as well as impaired hepatic blood flow according to ultrasound. Conclusion. Indicators of FSI, ALT/AST ratio, ratio of TG and LDL-С to HDL-C as well as assessment of hepatic blood flow indicators can be used for early diagnosis of nonalcoholic fatty liver disease, as they predict liver steatosis.